The joint NHS Greater Glasgow and University of Glasgow project 'Glasgow Biomedicine' is part of Medicine in Glasgow, a unique collaboration aiming to develop and promote Glasgow as an international centre of medical excellence.
The Glasgow Biomedicine project, which is supported by Scottish Enterprise Glasgow, is set to boost research and facilitate clinical trials in the city. The founders hope to attract commercial business to Glasgow and create a one-stop-shop for clinical expertise.
The trials are set to help sufferers of common diseases such as cardiovascular disease, diabetes, cancer, infectious diseases and neurological problems. The clinical trials organisation will coordinate these activities across the city, helping to deliver new treatments swiftly from laboratory bench to patient bedside.
Kerr said: "I'm delighted to attend the launch of Glasgow Biomedicine to promote the excellent standard of clinical trial work in Scotland. An expansion of our clinical trials in Scotland will not only help improve the health of our population but will also enhance the economic standing of our country."
Dr. Allan Gaw, Director of Clinical Trials Unit at Glasgow Royal Infirmary, mentioned that "although Glasgow has a long track record of successfully running clinical trials, our capability is currently sometimes fragmented. Glasgow Biomedicine will help to improve the health of the city and develop new drugs to advance health internationally."
Commercial and non-commercial trials are essential for medical practice to be taken forward and for new drugs to be developed, say the initiators. "Volunteers who take part in such clinical trials usually feel they have made a major contribution. Participants are always given advice on their condition and are given a real chance to tackle their illness in new ways.”
MEDICA.de; Source: University of Glasgow